Get your coffee ready because it's biotech time. Let's talk about biotech approvals, Carl, and what's going on at the FDA, because it does seem as though things are a little bit, let's call it ...

Biotechnology is no longer distant science fiction; it’s already a growing force in both national security and local economies. It affects everything from how much you pay at the pharmacy to whether ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Emerging from a grassroots LinkedIn group effort and with co-founder Rob Perez leaning in to grow the initiative, 2026 is shaping up to be the year of BLOC—Biopharma Leaders of Color. “The thing that ...

BioTechAnalyzer is a research and analytics platform focused on making complex FDA-related biotechnology information clear, accessible, and actionable for investors. The platform focuses on late-stage ...

Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied about 35% over the past six months (as of Nov. 20, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 12%). Year to ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

The term can be seen by some as a buzzword, but the need for workers to be able to articulate what they are doing and why it matters — and to be able to craft it in a compelling way for different ...

The biotech group has struggled as a whole in 2025, but analysts say the innovation that has always supported the biotech ...

Slow rolling chaos at the FDA and its effects on drug approvals. How to think about risk when investing in biotech. A review of results from DNA researcher Twist Bioscience. Don't wait! Be sure to get ...